Edward Penhoet

Edward Penhoet is a declared insider at 7 companies; the most frequent names are Renovis Inc, Corcept Therapeutics Inc and IDM Pharma, Inc. We count 36 filings; the first trade dates from 2 March 2006 and the latest from 29 July 2014.

Market trades split into 3 purchases (€3.0M) and 4 sales (€11.1M). Netting one side against the other leaves €8.1M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 5 option exercises. In 2014 alone, the filings show 1 purchase and no sales.

The median purchase comes to €312k.

On 31 July 2014 came the latest disclosure, a transaction in Immune Design Corp. The clock since the last published purchase (31 July 2014) now reads 4,467 days. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.